Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States

2016 ◽  
Vol 33 (6) ◽  
pp. 483-492 ◽  
Author(s):  
Sabrina L. Dickey ◽  
Eileen M. Cormier ◽  
James Whyte ◽  
Lucinda Graven ◽  
Penny A. Ralston
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Social Support ◽  
African American ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
White Men ◽  
The United States

Analysis of the First-Year Cost of a Prostate Cancer Screening and Treatment Program in the United States

1994 ◽  
Vol 86 (23) ◽  
pp. 1790-1792 ◽  
Author(s):  
W. L. Lubke ◽  
S. A. Optenberg ◽  
I. M. Thompson
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Treatment Program ◽  
Prostate Cancer Screening ◽  
The United States ◽  
First Year

Impact of the United States Preventive Services Task Force ‘D’ recommendation on prostate cancer screening and staging

2017 ◽  
Vol 27 (3) ◽  
pp. 205-209 ◽  
Author(s):  
Renu S. Eapen ◽  
Annika Herlemann ◽  
Samuel L. Washington ◽  
Matthew R. Cooperberg
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Task Force ◽  
Prostate Cancer Screening ◽  
Preventive Services ◽  
The United States

PD44-05 CONTEMPORARY NATIONAL TRENDS OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Simon Kim ◽  
R. Jeffrey Karnes ◽  
Cary Gross ◽  
Holly Van Houten ◽  
Robert Abouassaly ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
The United States ◽  
National Trends ◽  
Insured Patients ◽  
Privately Insured

Prostate Cancer Screening for Gay Men in the United States

Urology ◽  
2021 ◽  
Author(s):  
Rand N. Wilcox Vanden Berg ◽  
Spyridon P. Basourakos ◽  
Jonathan Shoag ◽  
Douglas Scherr ◽  
Bashir Al Hussein Al Awamlh
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Gay Men ◽  
Prostate Cancer Screening ◽  
The United States

Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States

Urology ◽  
2016 ◽  
Vol 97 ◽  
pp. 111-117 ◽  
Author(s):  
Simon P. Kim ◽  
R. Jeffrey Karnes ◽  
Cary P. Gross ◽  
Neal J. Meropol ◽  
Holly Van Houten ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
The United States ◽  
National Trends ◽  
Privately Insured

scholarly journals Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States

2011 ◽  
Vol 29 (13) ◽  
pp. 1736-1743 ◽  
Author(s):  
Michael W. Drazer ◽  
Dezheng Huo ◽  
Mara A. Schonberg ◽  
Aria Razmaria ◽  
Scott E. Eggener
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Life Expectancy ◽  
Prostate Cancer Screening ◽  
Specific Antigen ◽  
Older Men ◽  
The United States ◽  
Population Based ◽  
Psa Screening

Purpose For patients who elect to have prostate cancer screening, the optimal time to discontinue screening is unknown. Our objective was to describe rates and predictors of prostate-specific antigen (PSA) screening among older men in the United States. Methods Data were extracted from the population-based 2000 and 2005 National Health Interview Survey (NHIS). PSA screening was defined as a PSA test as part of a routine exam within the past year. Demographic, socioeconomic, and functional characteristics were collected, and a validated 5-year estimated life expectancy was calculated. Age-specific rates of PSA screening were determined, and sampling weight-adjusted multivariate regressions were fitted to determine predictors of screening among men age 70 years or older. Results The PSA screening rate was 24.0% in men age 50 to 54 years, and it increased steadily with age until a peak of 45.5% among age 70 to 74 years. Screening rates then gradually declined by age, and 24.6% of men age 85 years or older reported being screened. Among men age 70 years or older, screening rates varied by estimated 5-year life expectancy: rates were 47.3% in men with high life expectancies (≤ 15% probability of 5-year mortality), 39.2% in men with intermediate life expectancies (16% to 48% probability), and 30.7% in men with low life expectancies (> 48% probability; P < .001). In multivariate analysis, estimated life expectancy and age remained independently associated with PSA screening (P < .001 for each). Conclusion Rates of PSA screening in the United States are associated with age and estimated life expectancy, but excessive PSA screening in elderly men with limited life expectancies remains a significant problem. The merits and limitations of PSA should be discussed with all patients considering prostate cancer screening.

scholarly journals PD09-02 PROSTATE CANCER SCREENING AND REFERRAL PATTERNS IN THE YEARS SURROUNDING THE UNITED STATES PREVENTATIVE SERVICES TASK FORCE RECOMMENDATION AGAINST PSA SCREENING IN ALL MEN

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Ryan Hutchinson ◽  
Abdulhadi Akhtar ◽  
Justin Haridas ◽  
Deepa Bhat ◽  
Claus Roehrborn ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Task Force ◽  
Prostate Cancer Screening ◽  
The United States ◽  
Referral Patterns ◽  
Psa Screening ◽  
Preventative Services

478: Relationship between Obesity and Prostate Cancer Screening in the United States

2006 ◽  
Vol 175 (4S) ◽  
pp. 155-155
Author(s):  
Charles D. Scales ◽  
Lesley H. Curtis ◽  
Regina D. Norris ◽  
Kevin A. Schulman ◽  
Philipp Dahm ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
United States ◽  
Cancer Screening ◽  
Prostate Cancer Screening ◽  
The United States
Sign in / Sign up

Export Citation Format

Share Document